Yael Cohen

Clinical research professional with over 25 years of experience in the pharmaceutical industry leading all aspects of Phase I, II, and Phase III complex registrational clinical trials of drugs, devices, and drug-device combination in a global environment. Expertise across various indications, mainly in CNS.

Previously served as Director of Global Clinical Operations at NeuroDerm Ltd. for 4 years responsible for the operational execution of global development programs in Parkinson’s Disease, which included oversight of 5 clinical trials in parallel, Phase I, II and III, including responsibility for a budget of several millions of dollars. From 2004 to 2014, Ms. Cohen held positions of increasing responsibility in clinical operations at several Israeli start-up companies, including three years of relocation in the US, managing the registrational study of Evolence. Previously Ms. Cohen served as a Senior Clinical Research Associate at BMS, a global pharmaceutical company. She received both her B.Sc. in Pharmacy and M.Sc in Clinical Pharmacy from the Pharmacy school at the Hebrew University of Jerusalem.